scispace - formally typeset
Open AccessJournal ArticleDOI

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.

Mahmoud B. Malas, +5 more
- 01 Dec 2020 - 
- Vol. 29, pp 100639-100639
TLDR
Robust evidence from ongoing clinical trials is needed to determine the impact of thromboprophylaxis on TE and mortality risk of COVID-19.
About: 
This article is published in EClinicalMedicine.The article was published on 2020-12-01 and is currently open access. It has received 492 citations till now. The article focuses on the topics: Mortality rate & Risk of mortality.

read more

Citations
More filters

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, +19 more
TL;DR: Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
Journal ArticleDOI

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

- 22 Feb 2022 - 
TL;DR: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update as discussed by the authors .
Journal ArticleDOI

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

- 21 Feb 2023 - 
TL;DR: The 2023 Statistical Update as mentioned in this paper provides the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health.
Journal ArticleDOI

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.

Sarah E Daugherty, +7 more
- 19 May 2021 - 
TL;DR: The authors in this paper evaluated the risk of developing new clinical sequelae after the acute phase of SARS-CoV-2 infection, including specific types of sequelae less commonly seen in other viral illnesses, including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety, and fatigue.
Journal ArticleDOI

Delirium in Older Patients With COVID-19 Presenting to the Emergency Department.

Maura Kennedy, +23 more
TL;DR: It is suggested that older adults with COVID-19 commonly present to the emergency department (ED) with delirium and thatDelirium should be considered an important presenting symptom of CO VID-19.
References
More filters
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher, +4 more
- 21 Jul 2009 - 
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

David Moher, +4 more
- 21 Jul 2009 - 
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, +28 more
- 24 Jan 2020 - 
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI

Meta-Analysis in Clinical Trials*

Rebecca DerSimonian, +3 more
- 01 Sep 1986 - 
TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
Journal ArticleDOI

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher, +4 more
- 18 Aug 2009 - 
TL;DR: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is introduced, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses.
Related Papers (5)

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Ning Tang, +3 more
- 01 Apr 2020 - 

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Fei Zhou, +19 more
- 28 Mar 2020 - 

Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Frederikus A. Klok, +10 more
- 10 Apr 2020 - 

Clinical Characteristics of Coronavirus Disease 2019 in China.

Wei-jie Guan, +36 more
- 28 Feb 2020 - 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, +28 more
- 24 Jan 2020 -